Federal award
ORTHO-CLINICAL DIAGNOSTICS, INC
FA810116FA017
Contract
Obligated and Ceiling
- Obligated (net)
- $478,538.59
- Ceiling (potential value, not spending)
- $1,388,702.08
- Current value
- $480,938.59
- Gross positive obligations
- $487,777.55
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ORTHO-CLINICAL DIAGNOSTICS, INC · JG5JF2JQJ121
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ORTHO-CLINICAL DIAGNOSTICS, INC. · S2FCVS5TWDZ2
- Awarding agency
- Department of War · sub-agency 5700 · office FA8101
- Funding agency
- Department of War · sub-agency 5700
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- FA810116FA017
- Parent vehicle (IDV PIID)
- V797P7126A
- Award type code
- C
- Actions
- 10 · Mar 1, 2016 to Dec 3, 2025
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History10
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Dec 3, 2025 | FY2026 | P00009 | M | $0.00 | — |
| Aug 8, 2022 | FY2022 | P00008 | C | −$4,576.72 | — |
| Feb 9, 2021 | FY2021 | P00007 | G | $23,755.71 | — |
| Oct 8, 2020 | FY2021 | P00006 | C | −$2,400.00 | — |
| Feb 10, 2020 | FY2020 | P00005 | G | $95,022.78 | — |
| Feb 28, 2019 | FY2019 | P00004 | G | $95,022.78 | — |
| Feb 27, 2018 | FY2018 | P00003 | G | $83,930.72 | — |
| Aug 25, 2017 | FY2017 | P00002 | B | −$2,262.24 | — |
| Feb 22, 2017 | FY2017 | P00001 | G | $95,022.78 | — |
| Mar 1, 2016 | FY2016 | 0 | — | $95,022.78 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.